Sponsored

Granular intelligence is key to navigating the continent’s ESG landscape, say Kathryn Fletcher and Shawn Duthie at Control Risks.

In the second episode of our Disruption Matters miniseries, sponsored by AlixPartners, PE leaders share how they’re weathering operational and financial challenges. 

The first in a special five-part series, sponsored by AlixPartners, where we ask private equity operators how they're responding to today’s myriad challenges. 

A generation of nimble and ambitious Australian businesses represents an exciting investment opportunity, say Pacific Equity Partners’ Evan Hattersley and Rosie Johnson.

In a high-valuation environment, healthcare investors must push value creation harder than ever, says Guillaume Jabalot, director at Montagu.

Data has a key role to play in identifying diversity and inclusion priorities and tracking progress across business levels and jurisdictions, say Sanne Group’s Karlien De Bruin, Catherine Law and Stacey Relton.

The industry can help build better businesses, create jobs and deliver returns, while working together to drive meaningful progress on ESG and DE&I, says EBRD’s Anne Fossemalle.

Senior support and better communicating the benefits of a long-term career in private markets could help reduce attrition among female investment staff, say Goldman Sachs’ Nicole Agnew and Stephanie Hui.

GPs need to focus on embedding diversity of thought at the firm and portfolio level, while ensuring culture change is led from the top, says Emily Pollock, solutions director at Schroders Capital.

An ageing population, an upgrading industry with strong innovation capability and a wave of venture capital investment means the Chinese market is well-positioned for increased healthcare interest, says Legend Capital’s Jafar Wang.